Novo Nordisk in the news
ShareCopied to clipboardAnalyze the latest Novo Nordisk news, with a current slightly positive sentiment polarity (0.48) or the entire set.
Latest news
Here are the latest news on this scope:
FTSE's winning streak on par with best ever run in 2017; Novo Nordisk rises 2%
CVS to boost access to Novo Nordisk's weight loss treatment Wegovy for patients on its drug plans
Novo Nordisk opens weight loss drug Wegovy to telehealth; Hims & Hers shares rocket 23%
Novo Nordisk scores major legal win that bars many compounded versions of Wegovy, Ozempic
Hims & Hers stock price soars after partnership with Novo Nordisk to offer weight-loss drug Wegovy
Novo Nordisk to continue largest insulin brand Mixtard supply in vials amid penfill device phase-out
Novo Holdings' earnings nearly doubled in 2024, despite Novo Nordisk's stock slump
Healthy Returns: Novo Nordisk scoops up Chinese obesity drug to compete with Eli Lilly
Novo Nordisk says copycat compounders are hurting Wegovy sales, may take legal action
Novo Nordisk defends disappointing next-gen obesity drug: 'It will be an important product'
SAP leapfrogs Novo Nordisk to become Europe's most valuable company
Novo Nordisk's weight loss drug Wegovy is now cheaper for even more patients
Novo Nordisk's next-gen obesity drug CagriSema had investors excited. Now they're not so sure
Stocks making the biggest moves premarket: JPMorgan Chase, Coinbase, Redfin, Novo Nordisk and more
Extract data
Extract all the news on this scope:
Visualize data
Here are some available charts on these news:
Evolution through time
Distribution of sources in the news
Distribution of sections in the news
Sentiment polarity through time